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OBJECTIVE: To compare therapeutic hypothermia (TH) treatment of term and near-term neonates with hypoxic-ischemic
encephalopathy (HIE) between neonatal units.
STUDY DESIGN: Population-based, retrospective analysis of TH initiation and maintenance, and of diagnostic imaging. The
comparison between units was based on crude data analysis, indirect standardization, and adjusted logistic regression.
RESULTS: TH was provided to 570 neonates with HIE between 2011 and 2018 in 10 Swiss units. We excluded 121 off-protocol
cooled neonates to avoid selection bias. Of the remaining 449 neonates, the outcome was favorable to international benchmarks,
but there were large unit-to-unit variations in baseline perinatal data and TH management. A total of 5% neonates did not reach
target temperature within 7 h (3–10% between units), and 29% experienced over- or undercooling (0–38%).
CONCLUSION: Although the neonates had favorable short-term outcomes, areas for improvement remain for Swiss units in both
process and outcome measures.
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INTRODUCTION
At the turn of the millennia, therapeutic hypothermia (TH)
became standard of care for neonates with moderate-to-severe
hypoxic–ischemic encephalopathy (HIE) in high-income coun-
tries [1–4]. Systematic reviews of cooling trials showed that TH
was able to reduce the combined outcome of death or major
neurodevelopmental disability in survivors up to childhood, with
a number needed to treat of 7 for an additional beneficial
outcome [2]. Long-term impairment among survivors still
remains an important issue [5]. Trials examining whether
pharmacological or nonpharmacological interventions in com-
bination with TH augment the neuroprotective effect of TH are
in progress. Until such add-on therapies are available, it is
essential to further optimize the clinical management for TH as
evidence suggests that current cooling protocols for 72 h are
reasonably close to optimal [6].
In 2011, Swiss neonatal units agreed on a cooling protocol for
standardized treatment of HIE based on those previously used
for randomized controlled trials (RCTs) [1]. However, RCTs have
well-defined protocols and independent data monitoring
committees to monitor the progress of a clinical trial, safety
data, and critical efficacy variables to guarantee conduction
according to the protocol. Such a thorough process cannot be
upheld in an everyday clinical setting. Real-world data are
collected outside the controlled restrictions of RCTs and are
therefore more representative of usual clinical practice [7]. In
order to monitor neonates with HIE and provide real-world
outcome data, the affected neonates were since registered in
the Swiss National Asphyxia and Cooling Register [8]. Several
benefits of maintaining a register for neonates with HIE have
since been discussed [9, 10]. A retrospective comparison
between neonates treated with TH before and after the
implementation of the Swiss register revealed an overall
improved management with reduced temperature variability,
more comprehensive improved neuromonitoring, and higher
follow-up rates [11]. A possible effect of treatment variations on
outcome was not investigated.
In this study, we analyze the adherence of the Swiss neonatal
units to the agreed standard TH protocol for all cooled neonates
between 2011 and 2018. We compared the resulting variation of
protocol deviations between units. To the involved units, this
provides feedback toward quality-improvement potential. To
everyone else, it displays where difficulties lied in implementing
TH in a real-world setting in contrast to those of RCTs. In a second
step, we test for the existence of known associations between
process deviations and short-term outcome in our collective to
measure the effect those deviations may have had on the
collective.
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METHODS
Data collection, evaluation, and publication for this study was approved by
the Swiss ethical committee and the Swiss Federal Commission for Privacy
Protection in Medical Research (KEK-ZH-Nr2014-0551 and KEK-ZH-Nr2014-
0552). Participating centers were obliged to inform parents about the
scientific use of anonymized data.
Study population
This was a population-based retrospective cohort study of prospectively
collected data on all Swiss neonates receiving TH between 2011 and
2018 (N= 578). Data of one unit contributing eight neonates had to be
excluded due to incompleteness of data. All other units complied to
data plausibility and completeness checks and annual data audits were
performed by the study coordinator (VR). Data collection was
performed at the National Asphyxia and Cooling Register hosted by
SwissNeoNet.
National protocol for standardized treatment of HIE
The standardized Swiss protocol (SSP) for treatment of HIE with TH was
implemented in 2011 (Supplement 1). It summarizes eligibility for TH,
target temperature, initiation and duration of TH, clinical management/
neuromonitoring, and neuroimaging during and after TH. It was based on
the results from basic research, protocols used for TH in RCTs, and reviews
on diagnostics [1, 12–17].
Perinatal characteristics and neurological assessment
Demographical maternal, pregnancy, delivery, and neonatal data were
extracted from the national register. The severity of HIE was measured by a
neurological examination using Sarnat or Thompson assessments.
Experienced neonatologist performed the examinations on admission
prior to cooling, and thereafter daily until rewarming was finished. In order
to compare severity of HIE on admission between centers, Thompson
scores (used by one center) were converted to Sarnat scores (used by all
other centers): Thompson scores 1–6 to Sarnat score 1, Thompson scores
7–12 to Sarnat score 2, and Thompson scores 13–22 to Sarnat score 3,
respectively [13, 18].
Process–quality indicators (QI)
The following processes defined by the SSP were analyzed for unit-specific
deviation from the protocol:
The term “off-protocol cooling” refers to neonates not fulfilling the
inclusion criteria for TH according to the SSP. This includes neonates with
mild HIE (Sarnat score = 1), neonates <35 weeks’ gestational age at birth,
neonates with life-threatening major congenital malformations, postnatal
age at the onset of TH > 6 h, or neonates that had neither of the following
clinical or biochemical conditions: an Apgar score <= 5 at 5 or 10min, a
continued need for resuscitation, or a pH <= 7.0, and a base deficit >= 16
mmol/L or lactate >= 12mmol/L in umbilical cord or blood sample with
60min after birth.
The protocol further instructs that TH should be started as soon as
practically possible, but within the first 6 h after birth. Target temperature
of 33.0–34.0 °C should be reached as soon as possible, optimally within one
to 2 h after initiation of hypothermia and maintained for 72 h. Hourly
temperature-point measures of core temperature by rectal probe were
recorded. We monitored all incidences where target temperature was not
reached within 7 h and defined this as a quality indicator. We monitored
whether the target temperature was maintained within range. To capture
large deviations and avoid random noise, over- or undercooling during TH
was defined as temperature being outside the target temperature for 3
consecutive hours during TH. The SSP targets rewarm at a rate of no more
than 0.2–0.5 °C per hour. We therefore monitored incidences where
rewarming was >0.5 °C per hour using an algorithm to capture the time
points when a temperature <34.0 °C was measured for the last time and
when 36.0 °C or above was recorded a first time.
We further monitored processes known to improve diagnostics and
prediction of outcome, i.e., whether a cerebral ultrasound (cUS) was
performed on admission and whether magnetic resonance imaging
(MRI) was performed between days 5 and 14 of life, i.e., after
termination of TH.
Although not specified by the SSP, we also analyzed the effect of passive
versus active cooling, as active cooling had shown greater temperature
stability in a prior publication of our group and centers had since gradually
changed to active cooling [11].
Outcome variables
The investigated short-term outcome QIs were arterial hypotension
(defined as “hypotension requiring treatment as defined by unit policies”
during day 1–4), seizures (defined as “clinical or subclinical seizures
identified on amplitude-integrated electroencephalogram during TH and
rewarming), infections (consisting of culture-proven sepsis or necrotizing
enterocolitis according to Bell stages 2 and 3 [19]), coagulopathy (any
disorder requiring treatment in order to maintain or recover normal
hemostasis according to unit’s policy), persistent pulmonary hypertension
(PPHN, severe hypoxemia disproportionate to the severity of lung disease,
evidence of a right-to-left shunt and other findings suggesting PPHN in
echocardiography and the need for medication), and mortality.
Statistical methods
Descriptive analysis of crude process QIs as well as indirectly standardized
unit-to-unit comparison using the entire pool of Swiss data as reference
population (=1) and 95% confidence intervals. We imputed missing data
(based on plausibility) as follows: of 10 neonates with unknown survival
status, 1 was determined as died due to a diagnosis of multiple-organ
failure, 4 were determined survivors due to complete 95 h temperature
monitoring and discharge-planning data, and 5 as survivors because of the
available 2 year follow-up data. A neonate with unknown birth location
was determined outborn based on place of birth.
To determine the quality indicators for TH start, over-/undercooling, and
rewarming, we used algorithms that scanned the hourly temperature
measurements recorded from hours 0 to 95 as of cooling start. The
algorithm required valid hourly temperature measurements per patient of
at least 80% of all temperatures during hours 0–11 for TH start, hours 0–71
for over-/undercooling during TH and hours 60–84 for rewarming at the
end of TH to determine when cooling started, where it varied over time,
when it ended, and how fast rewarming occurred. For each resulting QI,
data completeness of 90% of valid patient responses was required per
cooling center. Less than 90% data completeness was determined
unreliable and not evaluated.
Logistic regression was performed to analyze the associations between
process QIs and selected outcome measures. Adjustment for indirect
standardization and logistic regression was based on male sex, small for
gestational age, Sarnat score on admission, composite pregnancy
complication (maternal diabetes, maternal fever, or pre-eclampsia),
composite-delivery sentinel events (placental abruption, ruptured uterus,
shoulder dystocia, cord mishaps, or head entrapment), and being outborn.
All analyses were performed in R version 3.6.1 [20].
RESULTS
Study population
The Swiss National Asphyxia and Cooling Register registered 578
cooled neonates between 2011 and 2018 (Fig. 1). Data from 1 unit
(n= 8) was excluded due to incompleteness.
Of the 570 neonates receiving TH in the remaining 10 units, 118
were “off-protocol cooled neonates” (Table 1): 73 had mild HIE
(Sarnat score of 1), 15 were cooled after 6 h of postnatal age, 13
did not fulfill specified clinical/biochemical conditions, 10 were
<35 weeks’ gestation, and 7 had major malformations (Fig. 1). As
they introduce bias into the comparison between units and with
international data, all further analyses (including baseline char-
acteristic analysis) were based on the dataset of 449 neonates
fulfilling the inclusion criteria of the SSP.
Based on the 449 neonates receiving TH plus an estimated
missing 45 neonates from the excluded unit that was of average
size, plus the 46 neonates that were diagnosed with moderate-to-
severe HIE but were treated off-protocol, we estimate a total of
540 cases of moderate to severe HIE in Switzerland between 2011
and 2018. With 680,664 live births during the study period, this
yields a current period prevalence of ~0.8 per 1000 livebirths in
Switzerland.
Baseline characteristics
Considerable unit-specific variation in baseline pregnancy, mater-
nal, delivery, and neonatal characteristics of the 449 neonates is
shown in Table 1. The rates of outborns varied between 36% and















100% (neonatal unit based at a Children’s University Hospital with
no labor ward). Pregnancy complications ranged from 6 to 27%,
delivery sentinel events from 28 to 64%, birth weight was below
the 3rd percentile in 0–9%, umbilical artery pH was below 7.0 in
39–73% and base deficit was above 16mmol/L in 0–75% of cases.
To account for their effect in the comparison between units, these
parameters were adjusted for in the comparison of processes and
short-term outcome.
Processes
The high variation in baseline characteristics is mirrored in how
the units adhered to the SSP. For instance, neonates were
cooled off-protocol between 9 and 36% of cases (Table 1).
Quality indicators based on temperature measurements were
deemed reliable only when data completeness requirements
were met. The first three rows of Table 2 display the proportions
of incomplete data per unit per algorithm used. All measure-
ments for unit 8 as well as most measurements involving
rewarming were missing in more than 10% of neonates and
were therefore deemed as unreliable for this study. Of the
remaining data, variation between units was well observable
regarding mean time to reach target temperature that ranged
from 3.5 to 4.5 h and subsequently target cooling temperature
not being reached within 7 h in 3–10%, over- or undercooling
occurred in 0–38%, passive cooling in 0–100%, no cUS was
performed on admission in 4–47% and no MRI was performed
after cooling in 0–35%. Figure 2 displays the standardized, risk-
adjusted processes as observed over expected ratios with 95%
confidence intervals with the entire cohort as reference (=1).
Unreliable results were excluded. The above observed crude
unit-to-unit variations are less prominent after standardization.
However, some units display improvement potential when point
estimates lie on the right-hand side of the reference value,
particularly if confidence intervals do not overlap 1:. more-than-
expected neonates did not reach target temperature within 7 h
in units 1, 4, 6, 7, and 9; or they experienced over- or
undercooling in units 3, 4, and 7; or they were more often
cooled passively in unit 5; and cUS was not performed on
admission in more-than-expected neonates in units 2, 5, 7, and
10. The large confidence intervals displayed for target tempera-
ture not reached in 7 h may reflect the lack of predictive validity
of the risk-adjustment variables used, i.e., the lack of association
between the risk factors and the neonates being cooled too late.
Short-term outcomes
Of the 449 cooled neonates, 377 (84%) were discharged alive from
the units. Unit-specific data on short-term outcomes are depicted
in Table 2. Arterial hypotension was recorded in 32–89% of cases.
Clinical or subclinical seizures were recorded in 14–53%. Infection
rate varied between 0 and 16%. Neonatal deaths did not occur in
unit 6 (of the 11 included neonates, 7 were recorded with 2-year
follow-up and 4 with discharge data confirming survival) and
reached up to 27% in units 2 and 3. More details on unit-specific
outcome have recently been published by Grass et al. [21].
Association between process deviations and short-term
outcome
We performed an adjusted logistic regression to test possible
overall associations between observed process deviations and
short-term outcomes. Figure 3 displays that neonates experien-
cing any of the protocol deviations did not have noticeably higher
odds for adverse short-term outcome, except that infants that
were cooled passively had higher odds for hypotension or
infection and there was a tendency toward more PPHN for
overcooling or undercooling.
DISCUSSION
In this population-based survey of 570 neonates with HIE that
were treated with TH, we display large unit-to-unit variations in
deviations to the commonly agreed standardized Swiss protocol
for TH (SSP). Between units, 9–36% neonates received TH without
fulfilling the inclusion criteria (21% in total). These neonates were
excluded from further analysis to avoid selection bias. All of the
remaining 449 neonates had moderate-to-severe HIE. Compared
between units, 3–10% did not reach target temperature within the
foreseen timeframe and 0–38% experienced overcooling or
undercooling. Three units performed the rewarming period
generally according to the protocol, whereas the other units
could not be analyzed due to incomplete temperature recording.
None of the observable protocol deviations were associated with
adverse short-term outcome.
This study is largely based on the SSP, for TH. According to
Wassink et al., recent studies suggest that current protocols for TH
are near-optimal, and that the key to better neurodevelopmental
outcomes is earlier diagnosis and initiation of TH after birth [6].
The current protocols mentioned match the SSP which is why we
believe that this protocol is currently not in need of major revision.
However, earlier diagnosis of HIE may well be an area for potential
improvement in Swiss units. Our baseline characteristics reveal
considerable variation in pregnancy complications, delivery
sentinel events, delivery mode, and physiological measures during
delivery. As events during birth may affect infant outcome [22],
analyzing whether the displayed variation between units is
unwarranted and therefore avoidable may lead to opportunities
for earlier diagnosis and/or prevention of HIE.
Another area for potential improvement is earlier initiation of
TH. Thorensen et al. showed that children in which TH was started
before 3 h of age had significantly better psychomotor develop-
mental index scores at 18–24 months of age than those who were
cooled after three hours postnatal age [23]. In this study, mean
time to reach target temperature ranges from 3.5 to 4.5 h after
birth between units. As 30min are generally required to reach the
target temperature, earlier initiation or faster induction could be
another focus for improvement of TH management in Switzerland.
With an outborn rate of 76% among the Swiss neonates with
asphyxia, achieving earlier initiation is difficult but could be
Fig. 1 Study flow chart. *Estimated total number of neonates with
moderate to severe HIE in Switzerland 2011-2018: 449+ 45 (missing
unit of average unit size) + 46 (off-protocol cooled neonates with
moderate-to-severe HIE)= 540, i.e., ca. 68 per year. † major
malformations: 2 trisomy 21, 1 congenital diaphragmatic hernia, 1
transposition of the large vessels, 1 esophageal atresia, 1 hydrops
fetalis, 1 Turner syndrome, 1 microcephalia. HIE: hypoxic ischemic
encephalopathy; TH: therapeutic hypothermia.
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achieved by initiating active cooling during transport [24]. We also
plan an in-depth analysis of the Swiss data on whether earlier
initiation or faster induction of TH can lead to improved outcome.
To date, clear evidence on how strict a temperature range of
33.0–34.0 °C needs to be maintained during TH is not given [11].
Consistent clinical and preclinical findings however suggest that a
relatively broad range of cooling temperatures is beneficial for the
brain after HIE, and that it should not be necessary to reduce core
temperatures by more than ~3.5 °C, i.e., the targeted 33.5 °C that
was shown to be effective in clinical trials [6, 25]. We therefore
believe that some of the Swiss units have an improvement
potential by addressing measures to avoid over- and under-
cooling. Some of this potential may have already been addressed.
When the original SSP was agreed upon before the onset of this
study, there was no consensus sought regarding active versus
passive cooling. However a publication of our group in 2015
revealed greater temperature stability, i.e., less temperature
variability within the target range, for infants cooled actively
[11]. Afterward, all remaining units cooling passively gradually
changed to active cooling, including Unit 5 that switched in 2019,
after the end of this study’s recruiting period. Passive cooling
showed higher odds for infection and arterial hypotension in our
cohort. As passive cooling was performed to a largest part by unit
5 and this unit also had the highest rate of infection (Table 2), we
interpret these results as an effect of unit variation in short-term
outcome as recently published [21] rather than as an association
between passive cooling and the occurrence of infection or
hypotension.
There is no human data available regarding the optimal rate of
rewarming [26]. Rebound seizures have been described in human
neonates [27] and animal newborn models of HIE injury [28] even
with a rewarming rate of 0.5° per hour. Animal data suggest that
slow rewarming may improve neurodevelopmental outcome by
not reversing the effect of neuroprotection through the release
and accumulation of excitatory neurotransmitters [29]. Recent
experimental data suggest that the overall duration of cooling is
the critical determinant of outcome rather than the rate of
rewarming [26]. However, in neonates, Mitra et al. showed that
mitochondrial injury and low cerebral metabolic rate in neonatal
brain with moderate to severe ischemic injury persists even after
TH during the rewarming period in comparison with neonates
with evidence of mild brain injury [30]. This underlines that the
rewarming period is a vulnerable phase in neonates with HIE after
TH and slow rewarming might be safer until further data are
available. Apart from those units that display rewarming according
to the protocol, we therefore believe that better monitoring and
servo-controlled devices are the key for the remaining units to
ensure slow rewarming.
Cranial ultrasound (cUS) studies emphasize the importance of
cUS in neonates with HIE [31]. cUS immediately after birth can
demonstrate congenital structural cerebral abnormalities, fetal
brain injury, and detect abnormalities due to other causes of
Fig. 2 Unit specific standardized mortality/morbidity ratio overview with 95% confidence intervals of process deviations. Standardized,
risk-adjusted processes as observed over expected ratios with the entire cohort as reference (=1). *analysis of survivors only.
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neonatal encephalopathy, such as hypoplastic corpus callosum in
cases of nonketotic hyperglycinemia, germinolytic cysts in
mitochondrial or peroxismal disorders, and severe white matter
echogenicity in molybdenum cofactor deficiency, also referred to
as “HIE-mimics” [26, 31, 32]. In our study, the rate at which cUS was
performed on the day of admission varied strongly. This may
reflect that cUS is performed by neonatologists in some units,
whereas radiologists perform them in others and imaging is
restricted to daytime. Alternatively, it may reflect the varying
degree of importance attributed to early cUS imaging by
clinicians. We are currently organizing regular cUS courses to
better explain the rationale of early cUS imaging aiming to
increase rates further.
MRI is the optimum technique to detect perinatally acquired
cerebral lesions, and the pattern and severity of the lesions provide
a reliable guide to prognosis of neurodevelopmental outcome up
to childhood [17, 33, 34]. A recent prospective multicenter cohort
study showed that proton magnetic spectroscopy resonance
biomarkers (MRS) independently gave substantial improvement
in prognostic accuracy over available clinical measures and
conventional MRI scoring in cooled neonates. Proton MRS is hence
among the most powerful predictors for outcomes in neonates
with HIE [15, 35]. By emphasizing the importance of imaging MRI in
our regular register meetings, we hope to raise the awareness of
the potential for both imaging modalities.
The short-term outcomes reported in our study are discussed in
detail in a recent publication [21]. It summarizes the difficulty in
comparing outcomes between units that have different
approaches for diagnosing arterial hypotension or different
degrees of expertise in detecting seizures. In comparison with
United Kingdom (UK) TOBY Cooling Register cohort and a Dutch
cohort, our overall outcomes are comparable or lower: [9, 36]. The
overall period prevalence of HIE requiring TH is ca. 0.8 per 1000
livebirths in Switzerland and thus lower than the 1–1.5 estimated
for the UK. Mortality was 32% in the Dutch, 20% in the UK TOBY,
and 16% in our cohort; infections were 19% in the Dutch, 21% in
the UK TOBY, and 7% in our cohort; arterial hypotension was 81%
in the Dutch, 40% in the UK TOBY, and 67% in our cohort; seizures
were 44% in the UK TOBY, and 36% in our cohort; coagulopathy
was 44% in the Dutch, 31% in the UK TOBY, and 41% in our
cohort; PPHN was 28% in the Dutch and 18% in our cohort.
The lack of observed association between process deviations
and short-term outcomes in our study results either from too few
neonates experiencing the deviation, a too small difference
between neonates treated per protocol and those experiencing
a deviation, or a limited importance in adhering to the
recommended target temperatures on short-term outcomes. The
first two would hint toward a limited degree of compromised
quality in the Swiss cohort due to protocol deviations, the latter to
a limited importance of adhering to the protocol itself. Based on
the available literature listed, we favor the first interpretation.
The majority of neonates receiving TH without fulfilling the
inclusion criteria had mild HIE, their cooling was initiated after 6 h
or they had a lower gestational age. For neonates with mild HIE,
the benefit of TH has never formally been tested, however there is
growing evidence that neonates with mild HIE suffer from adverse
cognitive and neuromotor outcome [37]. Although in that study,
intact survival was greater after mild than moderate or severe HIE,
there was no significant difference in the cognitive outcomes of
neonates who had mild or moderate HIE among the survivors.
Disability occurred in up to 16% in this cohort of untreated mild
HIE, mostly affecting language abilities [37]. This is consistent with
a recent MR imaging study which showed cerebral injuries in 54%
of the neonates with mild HIE [38].
Although minor benefits have been reported for neonates with
moderate HIE in whom cooling was initiated after 6 h, the
effectiveness of this form of TH is yet uncertain [39, 40]. Also, a
higher mortality has been reported for neonates with lower
gestational age, however, there may have been selection bias
[6, 9]. In short, there is no clear view on a benefit–harm ratio for
neonates in which TH is considered to be used off-protocol and
more research is urgently needed. An analysis of long-term
outcomes at 2 and 5 years of our off-protocol cooled children is
planned.
The SSP was based on the procedures developed during RCTs,
in particular Azzopardi et al. [1], as RCTs are the gold standard for
evidence-based methods. Implementation of highly specialized
procedures from RCTs into a real-world setting may however raise
issues about applicability of experimental findings and inclusion
criteria [7, 41]. Different interpretation of processes and outcomes
of RCTs, different views on statistical significance, and clinical
importance as well as different local contexts will lead to variation
between healthcare providers [42–44]. Such variations are to be
expected and are usually more frequent than anticipated [45]. Our
study reveals how evidence-based findings for the care of
neonates with HIE were implemented in a near-population-
based setting, the resulting variations between units, their lack
of measurable effect on short-term outcomes and their resulting
potential for quality improvement when placing those variations
into the context of literature published after the SSP was
agreed upon.
The strengths of our study lie in the geographical, near
population-based setting, the prospective nature of data collec-
tion for quality assessment, the large number of neonates
included, and the real-world nature of a cohort study versus a
clinical trial. Simultaneously, as in any cohort study, we are faced
with several sources of potential bias. We believe to have met the
major confounders by introducing standardization and risk
adjustment. However, the limited data completeness in tempera-
ture measurements may have introduced bias into the analysis of
some units and disabled an analysis of rewarming after TH. With
this study, we believe to have demonstrated the importance of
Fig. 3 Adjusted odds ratios with 95% confidence intervals to reveal possible associations between process deviations and short-term
outcome. Symbol (*) shows analysis of survivors only. Target temp. not reached in 7 h: none of the infants cooled >7 h died.
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maintaining a national registry monitoring baseline characteristics,
processes and outcome as suggested by other researchers [9–11].
In conclusion, this study presents a unit-to-unit comparison of
internationally agreed-upon standardized procedures for TH. We
present population-based data of 449 neonates with moderate-to-
severe HIE receiving TH at 10 units. Large variations between units
can be observed for perinatal baseline characteristics as well as for
deviations to the standardized Swiss protocol (SSP) for TH,
particularly concerning reaching and maintaining target tempera-
ture during TH. None of the observed deviations however
translate directly into higher odds for adverse short-time outcome.
We conclude that overall, Swiss units have internationally
comparable or lower proportions of adverse short-term outcome
for neonates with moderate-to-severe HIE, but still display
considerable improvement potential that would benefit these
neonates, in particular regarding early diagnosis, early initiation,
and better monitoring of TH. A long-term outcome comparison is
required to substantiate these findings.
DATA AVAILABILITY
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